New User? Sign Up | Sign In

Insider Trading - Shah Rajeev M.

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Shah Rajeev M.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-10-31
Purchase
2016-10-31
8:46 pm
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
161,538 $13 $2,099,994 1,351,808
(Indirect)
View
2017-07-25
Purchase
2017-07-26
4:31 pm
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
533,333 $15 $7,999,995 2,113,236
(Indirect)
View
2017-10-12
Purchase
2017-10-16
4:31 pm
KalVista Pharmaceuticals Inc. KALV Shah Rajeev M.
Director
10% Owner
850,000 $8.5 $7,225,000 1,441,070
(Indirect)
View
2018-01-30
Purchase
2018-01-30
5:43 pm
Solid Biosciences Inc. SLDB Shah Rajeev M.
Director
1,000,000 $16 $16,000,000 2,689,444
(Indirect)
View
2018-02-14
Purchase
2018-02-16
4:42 pm
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
10% Owner
2,500,000 $6 $15,000,000 3,851,808
(Indirect)
View
2018-06-22
Purchase
2018-06-22
7:00 pm
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
1,058,824 $17 $18,000,008 2,162,671
(Indirect)
View
2018-10-03
Purchase
2018-10-05
4:34 pm
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
10% Owner
2,424,242 $8.25 $19,999,997 4,537,478
(Indirect)
View
2018-12-12
Purchase
2018-12-14
6:14 pm
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
10% Owner
1,006,452 $15.5 $15,600,006 4,858,260
(Indirect)
View
2019-09-17
Purchase
2019-09-17
4:05 pm
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
1,333,333 $15 $19,999,995 4,681,858
(Indirect)
View
2019-11-11
Purchase
2019-11-13
7:06 pm
89bio Inc. ETNB RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,500,000 $16 $24,000,000 1,500,000
(Indirect)
View
2020-02-03
Purchase
2020-02-05
5:58 pm
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
1,000,000 $19 $19,000,000 353,814
(Indirect)
View
2020-02-14
Purchase
2020-02-19
4:30 pm
scPharmaceuticals Inc. SCPH RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
271,993 $8.2 $2,230,343 3,247,005
(Indirect)
View
2020-02-14
Purchase(A)
2020-02-21
4:46 pm
scPharmaceuticals Inc. SCPH RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
271,993 $8.2 $2,230,343 3,518,998
(Indirect)
View
2020-03-13
Purchase
2020-03-13
6:47 pm
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
10% Owner
6,337,135 $7.89 $49,999,994 10,874,613
(Indirect)
View
2020-03-16
Purchase
2020-03-17
4:31 pm
IMARA Inc. IMRA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
625,000 $16 $10,000,000 1,454,348
(Indirect)
View
2020-03-27
Purchase
2020-03-31
5:02 pm
Phathom Pharmaceuticals Inc. PHAT RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
60,600 $24.58 $1,489,264 3,707,408
(Indirect)
View
2020-04-01
Purchase
2020-04-03
4:30 pm
Phathom Pharmaceuticals Inc. PHAT RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
117,600 $24.86 $2,923,642 3,825,008
(Indirect)
View
2020-04-27
Sale
2020-04-29
4:30 pm
Verastem Inc. VSTM RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
1,301,300 $2.307 $3,002,099 17,303,352
(Indirect)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-10-31
Conversion
2016-10-31
8:46 pm
N/A
N/A
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
616,646 $0 1,351,808
(Indirect)
View
2016-10-31
Conversion
2016-10-31
8:46 pm
N/A
N/A
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
573,624 $0 1,351,808
(Indirect)
View
2016-10-31
Conversion
2016-10-31
8:46 pm
N/A
N/A
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
4,316,531 $0 1,351,808
(Indirect)
View
2016-10-31
Conversion
2016-10-31
8:46 pm
N/A
N/A
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
4,015,378 $0 1,351,808
(Indirect)
View
2016-11-21
Option Award
2016-11-23
7:51 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Shah Rajeev M.
Director
591,070 $0 591,070
(Indirect)
View
2017-03-23
Option Award
2017-03-27
7:09 pm
N/A
2027-03-22
KalVista Pharmaceuticals Inc. KALV Shah Rajeev M.
Director
12,000 $7.88 12,000
(Direct)
View
2017-06-20
Option Award
2017-06-22
6:13 pm
N/A
2027-06-20
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
15,000 $22.37 15,000
(Direct)
View
2017-07-19
Option Award
2017-07-21
4:19 pm
N/A
2027-07-18
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
10% Owner
12,960 $15 12,960
(Direct)
View
2017-07-25
Conversion
2017-07-26
4:31 pm
N/A
N/A
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
1,579,903 $0 2,113,236
(Indirect)
View
2017-07-25
Conversion
2017-07-26
4:31 pm
N/A
N/A
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
3,819,444 $0 2,113,236
(Indirect)
View
2017-07-25
Conversion
2017-07-26
4:31 pm
N/A
N/A
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
4,409,170 $0 2,113,236
(Indirect)
View
2017-09-27
Option Award
2017-09-29
7:18 pm
N/A
2027-09-26
KalVista Pharmaceuticals Inc. KALV Shah Rajeev M.
Director
6,000 $6.71 6,000
(Direct)
View
2018-06-12
Option Award
2018-06-15
10:51 am
N/A
2028-06-11
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
12,960 $13.73 12,960
(Direct)
View
2018-06-22
Conversion
2018-06-22
7:00 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
1,103,847 $0 2,162,671
(Indirect)
View
2018-06-22
Conversion
2018-06-22
7:00 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
922,950 $0 2,162,671
(Indirect)
View
2018-06-28
Option Award
2018-07-02
07:24 am
N/A
2028-06-28
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
10% Owner
15,000 $9.9 15,000
(Direct)
View
2018-07-01
Option Award
2018-07-03
7:03 pm
N/A
2028-06-30
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
43,056 $20.34 43,056
(Direct)
View
2018-07-25
Option Award
2018-07-26
6:36 pm
N/A
2028-07-25
Solid Biosciences Inc. SLDB Shah Rajeev M.
Director
1,835 $37.89 1,835
(Direct)
View
2018-12-13
Option Award
2018-12-17
4:09 pm
N/A
2028-12-13
Solid Biosciences Inc. SLDB Shah Rajeev M.
Director
8,165 $23.58 8,165
(Direct)
View
2019-06-05
Option Award
2019-06-07
4:01 pm
N/A
2029-06-04
Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director
21,000 $5.35 21,000
(Direct)
View
2019-06-11
Option Award
2019-06-13
4:36 pm
N/A
2029-06-11
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
10% Owner
15,000 $19.88 15,000
(Direct)
View
2019-06-12
Option Award
2019-06-13
9:23 pm
N/A
2029-06-11
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
21,528 $30.87 21,528
(Direct)
View
2019-06-13
Option Award
2019-06-14
4:15 pm
N/A
2029-06-13
Solid Biosciences Inc. SLDB Shah Rajeev M.
Director
10,000 $5.26 10,000
(Direct)
View
2019-07-25
Option Award
2019-07-29
4:32 pm
N/A
N/A
Solid Biosciences Inc. SLDB Shah Rajeev M.
Director
1,881,720 $4.65 4,571,164
(Indirect)
View
2019-09-17
Conversion
2019-09-17
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
1,642,879 $0 4,681,858
(Indirect)
View
2019-09-17
Conversion
2019-09-17
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
1,139,635 $0 4,681,858
(Indirect)
View
2019-09-17
Conversion
2019-09-17
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
365,530 $0 4,681,858
(Indirect)
View
2019-09-17
Conversion
2019-09-17
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
200,481 $0 4,681,858
(Indirect)
View
2019-09-17
Conversion
2019-09-17
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
1,642,879 $0 4,681,858
(Indirect)
View
2019-09-17
Conversion
2019-09-17
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
365,530 $0 4,681,858
(Indirect)
View
2019-09-17
Conversion
2019-09-17
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
1,139,635 $0 4,681,858
(Indirect)
View
2019-09-17
Conversion
2019-09-17
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
200,481 $0 4,681,858
(Indirect)
View
2019-11-11
Conversion
2019-11-13
7:06 pm
N/A
N/A
89bio Inc. ETNB RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,661,214 $0 1,500,000
(Indirect)
View
2019-11-11
Conversion
2019-11-13
7:06 pm
N/A
N/A
89bio Inc. ETNB RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
10,327,777 $0 1,500,000
(Indirect)
View
2020-01-23
Equity Swap
2020-01-24
5:11 pm
N/A
N/A
Synthorx Inc. THOR RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Shah Rajeev M.
10% Owner
9,724,598 $68 0
(Indirect)
View
2020-01-23
Equity Swap
2020-01-24
5:53 pm
N/A
N/A
Synthorx Inc. THOR RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Shah Rajeev M.
10% Owner
9,724,598 $68 0
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
956,723 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
163,353 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
186,749 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
181,783 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
70,770 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
30,526 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
2,885,295 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
492,643 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
563,204 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
548,224 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
213,429 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
92,063 $0 353,814
(Indirect)
View
2020-03-16
Conversion
2020-03-17
4:31 pm
N/A
N/A
IMARA Inc. IMRA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
829,348 $0 1,454,348
(Indirect)
View
2020-03-16
Conversion
2020-03-17
4:31 pm
N/A
N/A
IMARA Inc. IMRA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
1,741,358 $0 1,454,348
(Indirect)
View
2020-04-02
Disposition
2020-04-03
09:00 am
N/A
N/A
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
10% Owner
4,858,260 $48 0
(Indirect)
View
2020-04-02
Disposition
2020-04-03
09:00 am
N/A
2027-06-20
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
10% Owner
15,000 $22.37 0
(Direct)
View
2020-04-02
Disposition
2020-04-03
09:00 am
N/A
2028-06-28
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
10% Owner
15,000 $9.9 0
(Direct)
View
2020-04-02
Disposition
2020-04-03
09:00 am
N/A
2029-06-11
Ra Pharmaceuticals Inc. RARX Shah Rajeev M.
Director
10% Owner
15,000 $19.88 0
(Direct)
View
2020-05-27
Option Award
2020-05-29
4:06 pm
N/A
2030-05-27
Eidos Therapeutics Inc. EIDX Shah Rajeev M.
Director
21,528 $48.51 21,528
(Direct)
View